UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ALKS — Alkermes plc.
CIK 861177
NEW YORK, NY
Position in ALKS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$14,255,486
+$3,207,502 QoQ
Shares Held
403,153
+2.1% QoQ
Ownership
0.242%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 54.959035403432445.ToString("F0")%
Shared 0.ToString("F0")%
None 45.040964596567555.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $926,551,772 across 34 Drug Manufacturers - Specialty & Generic names. ALKS ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,398,351 | $519,929,066 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
207,309 | $122,930,085 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
571,719 | $75,318,257 | |
| 4 | VTRS |
Viatris Inc
|
3,964,630 | $53,562,146 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
486,498 | $36,900,870 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,526,922 | $36,539,240 | |
| 7 | ALKS |
Alkermes plc.
This page
|
403,153 | $14,255,486 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
443,527 | $9,207,616 |
All Filings in ALKS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,255,486 | 403,153 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $11,047,984 | 394,853 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $11,772,810 | 392,427 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $19,209,578 | 671,429 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,926,600 | 482,332 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $13,294,048 | 462,241 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,346,639 | 405,382 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,287,110 | 260,876 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,290,613 | 195,442 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,267,990 | 189,906 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,110,701 | 182,460 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,678,667 | 213,376 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,015,067 | 213,376 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,952,286 | 189,525 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,089,849 | 183,155 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,641,023 | 222,928 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,853,472 | 222,481 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,609,533 | 456,128 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $20,148,664 | 653,329 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,255,264 | 540,590 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $16,972,140 | 908,573 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $9,936,932 | 498,092 | Shares | Defined | 2021-03-01 | |
| 2020-06-30 | $4,268,586 | 219,917 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,492,608 | 242,206 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||